// App-Quantinova.ai

376 : Transforming growth factor beta and IL‐4/IL‐13 signaling collaborate to prevent abnormal cystic liver formation during Schistosoma mansoni infection.

Researchers

Presenter

  • David A. Cantu

Principal Investigators

  • Kristen Kindrachuk

  • Lee Borthwick

  • Richard Gieseck

  • Kevin M. Hart

  • Thirumalia R. Ramalingam

  • Kevin M. Vannella

  • Thomas A. Wynn

Medical Centers

  • Immunopathogenesis section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Washington, DC

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Genentech, San Francisco, CA

Locations

  • United States

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Transforming growth factor beta

Drug/Treatment

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved